Pinnacle Pharmaceuticals' Series B Round

Pinnacle Pharmaceuticals raised a round of funding on July 27, 2011. Investors include NewVa Capital Partners.

Pinnacle Pharmaceuticals is a pharmaceutical company developing critical-care therapeutics for urology, pain management, antibacterial, and oncology indications by leveraging its supramolecular chemis…

Articles about Pinnacle Pharmaceuticals' Series B Round: